The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SMZL), nodal (NMZL) and extranodal (ENMZL), as well as provisional entities (n = 76), according to the WHO classification. The most striking Ig gene repertoire skewing was observed in SMZL. However, restrictions were also identified in all other MZ lymphomas studied, particularly ENMZL, with significantly different Ig gene distributions depending on the primary site of involvement. Cross-entity comparisons of the MZ Ig sequence dataset with a large dataset of Ig sequences (MZ-related or not; n = 65 837) revealed four major clusters of cases sharing homologous ('public') heavy variable complementarity-determining region 3. These clusters included rearrangements from SMZL, ENMZL (gastric, salivary gland, ocular adnexa), chronic lymphocytic leukemia, but also rheumatoid factors and non-malignant splenic MZ cells. In conclusion, different MZ lymphomas display biased 
Introduction
The 2016 update of the WHO classification of tumors of the hematopoietic and lymphoid tissues [1] recognizes three distinct types of marginal zone (MZ) lymphoma: splenic MZ lymphoma (SMZL), nodal MZ lymphoma (NMZL) and extranodal MZ lymphoma (ENMZL). Provisional entities pertain to splenic B cell lymphoma leukemia unclassifiable (splenic diffuse red pulp lymphoma [SDRL] ; hairy cell leukemia variant) and pediatric NMZL. In addition, non-chronic lymphocytic leukemia (CLL)-type monoclonal B lymphocytosis potentially related to SMZL (also termed clonal lymphocytosis of MZ origin, CBL-MZ) [2, 3] has been recognized for the first time.
(Auto)antigenic stimulation and (micro)environmental interactions have been implicated in MZ lymphomagenesis. This claim is supported by: (1) the pronounced skewing of the immunoglobulin (Ig) gene repertoire of MZ lymphomas [4, 5] , (2) the strong association between chronic inflammation (due to infection or autoimmunity) and ENMZL [6] and (3) the increased incidence of genetic aberrations (recurrent translocations or gene mutations) affecting key components of B cell signaling pathways, further underscoring their significance in the natural history of these entities [7, 8] . However, despite significant advances in characterizing the biological landscape of MZ lymphomas, questions abound regarding their immune pathogenesis and precise ontogenetic relationships.
Here, we aimed to obtain insight into MZ lymphomagenesis through: (1) systematic characterization of the Ig gene repertoires in MZ lymphomas and (2) comparison of Ig sequences from different MZ lymphoma subtypes, newly recognized clonal entities (CBL-MZ) and non-malignant entities (persistent polyclonal B cell lymphocytosis), for which a MZ origin is speculated, against a large Ig gene sequence dataset. The MZ dataset included: (1) definite entities of MZ origin, namely SMZL, n = 353 cases; NMZL, n = 37 cases; ENMZL, n = 98 cases, (2) provisional entities of postulated MZ origin, including SDRL, n = 16 cases; CBL-MZ, n = 60 cases, (3) persistent polyclonal B cell lymphocytosis, n = 2 cases/286 sequences and (4) non-malignant MZ cells isolated from six spleen specimens free of neoplastic cells at histological inspection (non-malignant MZ), obtained at surgery for non-hematological cancer (n = 489 sequences) (see supplementary material, Supplementary materials and methods).
Materials and methods

Characterization of the studied Ig gene sequence dataset
Ig gene repertoire analysis was performed only for rearrangement sequences from definite clonal entities of MZ origin. Sequences from non-clonal MZ lymphoproliferations and/or non-malignant splenic MZ cells were used for cross-comparison purposes and the identification of stereotyped sequences; repertoire findings from these latter subgroups are summarized in supplementary material, Supplementary materials and methods. The study was approved by local ethics review committees.
PCR amplification and immunoinformatic analysis of IGHV-IGHD-IGHJ gene rearrangements
PCR amplification and sequence analysis of IGHV-IGHD-IGHJ gene rearrangements was performed as described previously [9] and stereotyped rearrangements were identified through the use of a validated bioinformatics algorithm [9] .
In order to ensure consistency, all sequences underwent a multi-level evaluation aimed at: (1) removing unproductive, incomplete and/or IGHV-IGHD-IGHJ gene rearrangement sequences with ambiguous characters and (2) eliminating redundancy. Rearrangements were classified as either unique (present only once in the investigated dataset) or recurrent (belonging to the same only a single representative sequence was considered for repertoire characterization and comparisons [10] .
Statistics
Comparisons and associations between different subgroups were performed with the use of descriptive statistics assessed using the chi-squared test or Fisher's exact test for independence. The significance level for all tests was set to p < 0.05. Statistical analyses were performed with the statistical package, SPSS version 22.0 (SPSS, Chicago, IL, USA). 
Results and discussion
Capitalizing on a large dataset of IGHV-IGHD-IGHJ gene rearrangement sequences available through our multi-institutional collaboration, we assessed the immunogenetic characteristics of MZ lymphomas and searched for stereotyped B cell receptor Ig sequences across MZ and MZ-related entities.
Ig gene repertoire analysis revealed restrictions in the use of particular IGHV genes in all examined MZ lymphomas indicating disease-biased patterns ( Figure 1A) . IGHV gene repertoire skewing was more pronounced in SMZL, where the IGHV1-2 gene was used by 27.8% of all cases, in keeping with published studies by us and others [4] ; no particular bias to any IGHV gene was noted amongst the HCV (+) SMZL cases of our cohort (see supplementary material, Supplementary materials and methods). In NMZL, the most frequently expressed IGHV genes were IGHV4-34 and IGHV1-69 (13.5% each). Finally, in ENMZL, the IGHV1-69 gene predominated (16.3%), albeit with significantly different distribution depending on the primary site of involvement (34.8% in salivary ENMZL, 19.2% in gastric ENMZL, 6.1% in ocular adnexa ENMZL, OAMZL, p = 0.008 for all comparisons) ( Figure 1B) . Information regarding Chlamydia psittaci infection status was available for 38 OAMZL [11] , of which 16 (42%) were positive. Even though not statistically significant, the IGHV3-23 gene predominated amongst C. psittaci-negative cases (6/22 versus 2/16 in positive cases; p = 0.27), whereas IGHV3-7 predominated among C. psittaci-positive cases (3/16 versus 1/22; p = 0.15). Helicobacter pylori status in gastric ENMZL cases was not available due to the retrospective nature of the study. Overall, these findings confirm and significantly extend previous observations about the existence of Ig gene repertoire biases in MZ lymphomas [12] [13] [14] .
Turning to somatic hypermutation (SHM) and following previously proposed definitions [4] , IGHV-IGHD-IGHJ gene rearrangements carrying IGHV genes with no SHM (100% V-REGION) identity to that of the closest germline gene (germline identity; Figure 3 . Public clonotypic rearrangements. VH CDR3 amino acid alignment of the four largest public clusters, i.e. clusters that were not disease-specific (comprising IGHV-IGHD-IGHJ gene rearrangements from a single entity) but rather included cases deriving from different MZ lymphoproliferations but also other lymphoma entities, as well as healthy and autoreactive clones; additional relevant information is provided in supplementary material, Table S1 . (A) cluster #3; (B) cluster #5; (C) cluster #12; (D) cluster #16. Construction of the logos was performed using WebLogo (http://weblogo.berkeley.edu/). Each letter represents a single amino acid; the size of the letter represents its frequency. Colors correspond to the physicochemical properties' color code used by IMGT [18] . The numbering of the clusters is not indicative of their characteristics, nor does it correspond to the nomenclature for stereotypes CLL subsets, but only concerns their succession in cluster identification.
GI) were assigned to a 'truly unmutated' subgroup, whereas sequences with 97-99.9% GI were classified as 'borderline/minimally mutated' and those with <97% identity as 'mutated'.
The vast majority of MZ lymphoma cases bore some impact of SHM. However, differences were identified between various MZ lymphoma subtypes regarding their SHM profiles. In particular, the proportion of truly unmutated cases ranged from 0% in ENMZL gastric cases to 12.2% in SMZL. Regarding the remaining cases bearing SHM, 37.3% of IGHV-IGHD-IGHJ gene rearrangements in SMZL were borderline/minimally mutated versus only 18.9% in NMZL and 18.3% in ENMZL (p = 0.02 and p = 0.0004, respectively).
Finally, only 50.4% of SMZL cases exhibited a significant SHM load versus 72.9 and 75.5% of NMZL and ENMZL cases (p = 0.008 and p < 0.0001, respectively) ( Figure 2) .
Following established bioinformatics approaches [9] we searched for stereotyped B cell receptor Ig sequences, i.e. IGHV-IGHD-IGHJ gene rearrangements with restricted antigen-binding site sequence motifs. Of the 66 401 IGHV-IGHD-IGHJ rearrangements included in the analysis, 40 103 (60.4%) were assigned to at least one stereotyped subset. Overall, 26 143 different clusters were recognized. Of these, 2499 (9.5%) included IGHV-IGHD-IGHJ gene rearrangements from a single entity and were considered as 'disease-specific', 420 A Xochelli et al whereas the remainder included rearrangements from different entities and were, thus, deemed 'public'.
Most clusters (17 844/26 143; 68.3%) contained only two sequences; of the remaining 8299 clusters with three or more members, 1653 (6.3% of all clusters) included six or more members. The vast majority of disease-specific clusters (2468/2499, 98.7%) concerned CLL cases, which is not paradoxical, considering that the incidence of B cell receptor Ig stereotypy is much higher in CLL versus all other B cell lymphomas thus far analyzed [15] . A much smaller proportion of 'disease-specific' clusters (31/2499, 1.2%) concerned MZ lymphomas, mostly SMZL.
Public clusters were mostly relatively small in size, with only four being populated by more than 20 members (see supplementary material, Table S1 ). All four large public clusters included somatically hypermutated IGHV-IGHD-IGHJ gene rearrangements that derived from MZ lymphomas, non-malignant splenic MZ cells and other conditions. Two of four subsets utilized the IGHV1-69 gene, whereas the remaining two utilized the IGHV3-7 and IGHV4-59 genes, respectively ( Figure 3 ). They included IGHV-IGHD-IGHJ gene rearrangements from various entities, including SMZL, ENMZL (gastric, salivary gland, ocular adnexa), CLL, hepatitis C virus-associated diffuse large B cell lymphoma and non-malignant splenic MZ cells and rheumatoid factors (with regards to the latter, recalling previous reports [11, 12, 16, 17] ). Notably, shared (recurrent) amino acid changes introduced by SHM (i.e. the same amino acid replacement at the same position) were identified in each large public cluster (see supplementary material, Tables S2-S5).
As the story of antigen-driven lymphoma unfolds, multidisciplinary investigation will be paramount to the identification of the selecting agent(s) and immune processes underlying the development of MZ lymphomas. Our present findings highlight biased immunogenetic signatures for distinct MZ lymphomas that pertain to both distinctive IGHV gene repertoires and differential SHM imprints. Although highlighting (auto)antigen selection pressure as a major driver in MZ lymphomagenesis, these results also suggest that unique immune pathways lead to distinct MZ lymphomas.
That said, the existence of rare public stereotypes raises the intriguing possibility that, occasionally, common patterns of immune stimulation triggered by distinct and/or cross-reactive (auto)antigens may result in diverse B lymphoproliferations due to targeting versatile progenitor B cells and/or operating in particular microenvironments. Future immunogenetic and functional studies are clearly warranted to test this hypothesis but also to offer answers as to how normal MZ cells, the presumed normal counterparts for several MZ lymphomas, are co-opted into pathogenic immune responses in these tumors; where does affinity maturation take place; and what is the significance of various bystander cells, particularly T cells. Table S1 . Only four public clusters were populated with more than 20 sequences. These included IGHV-IGHD-IGHJ gene rearrangements of different origin, such as MZ lymphomas, non-malignant spleen tissue and various other conditions, especially HCV-associated entities and autoimmune disorders. Minor public clusters (populated with less than 10 sequences) were also identified Table S2 . Recurrent amino acid changes introduced by SHM in cluster #3 Table S3 . Recurrent amino acid changes introduced by SHM in cluster #5 Table S4 . Recurrent amino acid changes introduced by SHM in cluster #12 
SUPPLEMENTARY MATERIAL ONLINE
Supplementary materials and methods
